Journal profile · Dermatology
Clinical and Experimental Dermatology
ISSN 0307-6938 · eISSN 1365-2230 · Wiley-Blackwell Publishing Ltd · ENGLAND · Bimonthly · Founded 1976
Clinical and Experimental Dermatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.74; hybrid open access; APC about USD 3,354; median 104 days to acceptance (152 articles, last 24 months); community-reported acceptance: easy; 576 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical and Experimental Dermatology is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Autoimmune Bullous Skin Diseases, Dermatology and Skin Diseases and Cutaneous lymphoproliferative disorders research, together about 22.7% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.
From the journal's Aims & Scope
Research area (LetPub): Dermatology
Editorial board by country: none in mainland China; most named United Kingdom 5, Austria 1 (6 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Autoimmune Bullous Skin DiseasesMedicine10.5%
- Dermatology and Skin DiseasesMedicine6.3%
- Cutaneous lymphoproliferative disorders researchMedicine5.9%
- Nail Diseases and TreatmentsMedicine5.7%
- Genetic and rare skin diseases.Biochemistry, Genetics and Molecular Biology5.3%
- Cancer and Skin LesionsMedicine5%
- Autoimmune and Inflammatory DisordersMedicine4.6%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Dermatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.74LetPub ·
- CiteScore 2026-06
- 3.1LetPub ·
- SJR 2026-06
- 0.66LetPub ·
- SNIP 2026-06
- 0.89LetPub ·
- h-index
- 71LetPub ·
- h-index
- 120OpenAlex ·
- i10-index
- 5,272OpenAlex ·
- 2-year mean citedness
- 1.34OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 20.52%LetPub ·
Volume
- Articles per year
- 271LetPub ·
Articles by year OpenAlex count · 12,828 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 414 | 81 | 77 |
| 2025 | 576 | 105 | 637 |
| 2024 | 553 | 98 | 1,349 |
| 2023 | 465 | 94 | 2,095 |
| 2022 | 483 | 128 | 2,504 |
| 2021 | 535 | 125 | 4,490 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
104 daysMedian, submission to acceptance · P25–P75 61 days – 172 days
- Acceptance to online
- median 7 days (62 articles)
- Submission to online
- median 139 days
- Sample
- 152 articles with submission and acceptance dates (1,369 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | GBP 2,543 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 1,200 words
- Reference style
- Vancouver
Article types accepted6, with length limits
- case reportClinical and Experimental Dermatology invites the following types of submission: Review Articles We publish concise, high-quality Review Articles covering both …Length not stated
- correspondenceClinical and Experimental Dermatology invites the following types of submission: Review Articles We publish concise, high-quality Review Articles covering both …Length not stated
- letter to the editorA letter to the editor may be in response to issues arising from recently published articles, or short, free-standing pieces expressing an opinion. Most corresp…main text ≤ 500 words · figures and tables ≤ 2 · references ≤ 5
- original articleClinical and Experimental Dermatology invites the following types of submission: Review Articles We publish concise, high-quality Review Articles covering both …Length not stated
- reviewClinical and Experimental Dermatology invites the following types of submission: Review Articles We publish concise, high-quality Review Articles covering both …Length not stated
- review articleClinical and Experimental Dermatology invites the following types of submission: Review Articles We publish concise, high-quality Review Articles covering both …main text ≤ 250 words · abstract ≤ 250 words · references ≤ 30
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints
- Authorship Corresponding authorship
CED’s policy is to allow only one corresponding author for an article and they should be designated at the time of submission. Changes to authorship are not allowed after acceptance unless there are exceptional circumstances, in which case an email will need to be sent to the Editor at CED@bad.org.uk explaining the rationale for such a change. The journal will then follow COPE’s process to ensure …
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
Authors are responsible for disclosing all financial and personal relationships between themselves and others that might be perceived to conflict with their current work in the past 36 months. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist. If no conflicts exist, state ‘The authors declare they have no conflicts of interest’. For more details, pl…
Source ↗Publisher website ·- Data availability Data Sharing
CED supports the principle that all data should be made available to facilitate research reproducibility, while protecting patient privacy and confidentiality. We expect that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When dat…
Source ↗Publisher website ·- Publication ethics COPE (Committee on Publication Ethics)
CED is a member of COPE and follows the processes as outlined by COPE. Occasionally the journal may seek the advice of COPE on certain ethical matters, and if deemed appropriate may choose to contact the authors’ institutions, following COPE’s guidance.
Source ↗Publisher website ·- Open access Open Access
If you want to publish your article open access, please refer to the Open Access section of the Wiley Online Library. You may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License. Standard re-use and licensing rights vary by journal. Note that certain funders mandate a particular type of CC license be used. Th…
Source ↗Publisher website ·- Peer review Peer Review
CED follows a single-blind process of peer review, where the reviewers know who the authors are, but the authors are not aware of the reviewers. Members of the editorial team, including the Editor, who submit papers (with the exception of editorials and commentaries) are blinded to the process and are not involved in the peer review or any aspect of decision making. CED’s peer review process is as…
Source ↗Publisher website ·- Plagiarism Plagiarism
CED takes plagiarism very seriously and follows COPE’s guidance if plagiarism is suspected. All accepted papers are put through plagiarism checking software and any flagged manuscripts are manually checked.
Source ↗Publisher website ·- Preprints Preprint
CED allows submissions of papers that have already been posted on a subject-based preprint server (e.g. bioRxiv or MedRxiv). Authors who post their work as a preprint are required to disclose this during submission. Details of the preprint server used must be included in the article, including the reference number or DOI. Once the paper has been accepted, authors are required to update prepublicat…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1976
- ISSN
- 0307-6938
- Electronic ISSN
- 1365-2230
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Clinical and Experimental Dermatology
What CAS zone is Clinical and Experimental Dermatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Experimental Dermatology is in Zone 4 of Medicine, and in Zone 3 of the minor category Dermatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Experimental Dermatology?
The latest impact factor listed by LetPub is 2.74; CiteScore 3.1, h-index 120.
How long does peer review take at Clinical and Experimental Dermatology?
Based on the dates recorded on 152 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 61–172 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical and Experimental Dermatology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 1,200 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical and Experimental Dermatology based?
Of the 6 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (5) and Austria (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Experimental Dermatology?
According to LetPub and DOAJ records, Clinical and Experimental Dermatology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Clinical and Experimental Dermatology open access, and what is the APC?
Clinical and Experimental Dermatology is a hybrid journal. For open-access publication: APC about USD 3,354.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .